IBD Ventures
IBD Ventures, from the Crohn's and Colitis Foundation, funds and accelerates research-driven product development to address unmet needs in Crohn’s disease and ulcerative colitis.
Funder: Crohn's and Colitis Foundation
Due Dates: September 18, 2026: Letter of Intent deadline
Funding Amounts: Up to $500,000 per project per year; renewable for additional years based on milestone achievement.
Summary: Supports innovative product development for inflammatory bowel disease through funding and accelerator resources.
Key Information: Both companies and academic investigators are eligible; LOI required before full proposal.
Description
This program accelerates the discovery and development of novel products to improve the quality of life for patients with inflammatory bowel diseases (IBD), including Crohn’s disease and ulcerative colitis. The initiative provides both financial support and access to accelerator resources such as scientific advising, strategic partnerships, and specialized research assets. The goal is to drive the translation of research into impactful therapies, diagnostics, devices, or digital health solutions that address unmet patient needs in IBD.
